MedTrace Logo

Evaluation of the Effectiveness of Extracorporeal Methods for Removing Mediators of Systemic Inflammation

NCT05182723 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-02-03

No results posted yet for this study

Summary

The purpose of this study is to assess the effectiveness and the safety of extracorporeal methods for removing mediators of systemic inflammation in patients with multiple organ dysfunction syndrome after heart and aorta surgery.

Conditions

Interventions

PROCEDURE

renal replacement therapy

Extracorporeal Methods for Removing Mediators of Systemic Inflammation

Sponsors & Collaborators

  • Petrovsky National Research Centre of Surgery

    lead OTHER

Principal Investigators

  • Aleksandr Eremenko, MD · Petrovsky National Research Centre of Surgery

  • Tatiana Marchenko · Petrovsky National Research Centre of Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-25
Primary Completion
2024-11-30
Completion
2025-05-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05182723 on ClinicalTrials.gov